130 related articles for article (PubMed ID: 15794955)
1. Listening to consumers and HIV vaccine preparedness.
Duan N
Lancet; 2005 Mar 26-Apr 1; 365(9465):1119-21. PubMed ID: 15794955
[No Abstract] [Full Text] [Related]
2. Participation in HIV vaccine trials: listening to participant & community concerns.
Mills EJ; Jha P
Indian J Med Res; 2006 Dec; 124(6):608-10. PubMed ID: 17287546
[No Abstract] [Full Text] [Related]
3. Boston: important trial of treatment vaccine, CD4 over 500.
AIDS Treat News; 1995 Aug; (no 228):4-5. PubMed ID: 11362626
[TBL] [Abstract][Full Text] [Related]
4. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT.
Serpelloni G; Vlahov D; Mazzi M; Rezza G
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):206-7. PubMed ID: 7552488
[No Abstract] [Full Text] [Related]
5. Is participation in HIV vaccine trials a health promoting behaviour?
Kafaar Z; Kagee A; Lesch A; Swartz L
AIDS Care; 2007 Nov; 19(10):1307-9. PubMed ID: 18071976
[TBL] [Abstract][Full Text] [Related]
6. An AIDS vaccine: a flickering light at the end of the tunnel.
Kent C
J Am Health Policy; 1994; 4(4):33-7. PubMed ID: 10136680
[TBL] [Abstract][Full Text] [Related]
7. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?
Newman PA; Duan N; Rudy ET; Anton PA
AIDS Patient Care STDS; 2004 Dec; 18(12):691-701. PubMed ID: 15659880
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Advances in AIDS Vaccine Development.
Snow W
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1433-4. PubMed ID: 1466975
[No Abstract] [Full Text] [Related]
9. Identifying barriers to participation in prophylactic HIV-1 vaccine trials.
Peters BS
Int J STD AIDS; 2006 Feb; 17(2):73. PubMed ID: 16464264
[No Abstract] [Full Text] [Related]
10. HIV vaccine trials for Africa.
AIDS Read; 2000 Sep; 10(9):524. PubMed ID: 11019443
[No Abstract] [Full Text] [Related]
11. AIDS doctors push for live-virus vaccine trials.
McCarthy M
Lancet; 1997 Oct; 350(9084):1082. PubMed ID: 10213561
[No Abstract] [Full Text] [Related]
12. AIDS research. More woes for struggling HIV vaccine field.
Cohen J
Science; 2013 May; 340(6133):667. PubMed ID: 23661729
[No Abstract] [Full Text] [Related]
13. India targets local HIV strain in test of AIDS vaccine.
Jayaraman KS
Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
[No Abstract] [Full Text] [Related]
14. Thorny issues in the ethics of AIDS vaccine trials.
Berkley S
Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
[No Abstract] [Full Text] [Related]
15. Why Brazil should not be a site for AIDS vaccine trials.
de Sá CA
Sao Paulo Med J; 1994; 112(3):577-9. PubMed ID: 7638516
[No Abstract] [Full Text] [Related]
16. First AIDS vaccine trials next year.
Bateman C
S Afr Med J; 2001 Aug; 91(8):622-3. PubMed ID: 11584770
[No Abstract] [Full Text] [Related]
17. The ethical involvement of women in HIV vaccine trials in Africa: discussion paper developed for the African AIDS Vaccine Programme.
Wassenaar DR; Barsdorf NW
Women Health; 2007; 45(1):37-50. PubMed ID: 17613461
[TBL] [Abstract][Full Text] [Related]
18. Should South Africa be preparing for HIV-1 vaccine efficacy trials?
Morris L; van der Ryst E; Gray C; Williamson C
S Afr Med J; 1997 Mar; 87(3):285-90. PubMed ID: 9137338
[No Abstract] [Full Text] [Related]
19. IAVI begins trials of AIDS vaccine.
Expert Rev Anti Infect Ther; 2003 Dec; 1(4):527. PubMed ID: 15490505
[No Abstract] [Full Text] [Related]
20. Scientific and policy challenges to development of an AIDS vaccine.
Berkley SF; Koff WC
Lancet; 2007 Jul; 370(9581):94-101. PubMed ID: 17617277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
